A long-anticipated bipartisan Senate bill to overhaul the 340B program appears on track for introduction before Congress enters recess at [...] …
Articles by : William Newton, Associate Editor/Senior Writer
The Delaware House late last week overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions on grantee covered [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A leading Virginia health center advocate published an op-ed late last week blasting Gov. Glenn Youngkin (R) for choosing “Big [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A political action committee (PAC) with close ties to a dark money group recently released a new ad threatening to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A draft Senate bill, which would offer bonus payments to hospitals that stockpile certain generic drugs and forgo other rebates [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Merck is fully exempting West Virginia covered entities from its 340B contract pharmacy restrictions, including all data submission requirements. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...] …
